The wire › SEC Form 8-K
AVADEL PHARMACEUTICALS PLC AVDL
Filed with the SEC on Feb 12, 2026. Reported event date Feb 12, 2026.
- Business address
- Dublin 2
- State
- Outside the U.S. or not given
- Incorporated in
- not given
- Industry
- Manufacturing (SIC 2834)
- SEC CIK
- 1012477
- Accession number
- 0001104659-26-013880
Items reported in this filing
- Item 1.02 Termination of a Material Definitive Agreement
- Item 2.01 Completion of Acquisition or Disposition of Assets
- Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
An exchange told the company it does not meet a continued-listing rule, or the company is delisting or moving its listing: Form 8-K Item 3.01. Many of these are compliance notices with time to fix, not closures.
- Item 3.03 Material Modification to Rights of Security Holders
- Item 5.01 Changes in Control of Registrant
- Item 5.02 Departure or Appointment of Directors or Officers; Compensatory Arrangements
- Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
- Item 7.01 Regulation FD Disclosure
- Item 9.01 Financial Statements and Exhibits
Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing